Q32 Bio H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Waltham, MA HQ🌐 q32bio.com
Does Q32 Bio sponsor H-1B visas?
Yes. Q32 Bio has filed 6 H-1B LCAs with the U.S. Department of Labor between FY2021 and FY2026. In FY2025 Q32 Bio filed 1 H-1B LCA at a median base salary of $182,000. No PERM green-card cases are on record.
It files most often for Associate Director, Regulatory Affairs roles, most in Waltham, MA.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2025 | 1 | $182k |
| FY2024 | 2 | $140k |
| FY2022 | 2 | $160k |
| FY2021 | 1 | $118k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Patents
- Granted
- 3
- US patents
- Published, not yet granted
- 3
- applications
- Most recent grant
- January 23, 2024
- Top area
- Peptides3
Pay against the local market
Q32 Bio’s most-filed occupations and metros, FY2024–FY2025. Its median base salary is 93% of the local BLS median for the same work.
| Occupation | Metro | Filings | Q32 Bio pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Natural Sciences Managers | Boston, MA | 1 | $125,000 | $219,380 | 57% |
| Data Scientists | Boston, MA | 1 | $155,000 | $131,830 | 118% |
| Managers, All Other | Boston, MA | 1 | $182,000 | $174,840 | 104% |
About Q32 Bio
- Legal name
- Q32 Bio Inc.
- Listed
- Nasdaq: QTTB
- Incorporated in
- Delaware
- Headquarters
- 830 Winter Street, Waltham, MA 02451
- Industry
- Pharma & biotech
- Website
- q32bio.com
- Revenue FY2023
- $1M -64% from $3M
- Net income FY2025
- $30M +162% from $-48M
- R&D FY2025
- $19M
H-1B sponsors similar to Q32 Bio
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Antares Pharma | 8 | 3 | $140k | 0 | — |
| Avidity Biosciences | 8 | 4 | $125k | 1 | — |
| Cellbae | 8 | 4 | $78k | 1 | — |
| Q32 Bio | 6 | 1 | $182k | 0 | — |
| Asklepion Pharmaceuticals | 6 | 1 | $500k | 0 | — |
| Bioalgo | 6 | 1 | $113k | 0 | — |
| Connect Biopharm | 6 | 2 | $140k | 0 | — |
